Market Research Logo

Obesity: The Worldwide Market for Pharmaceutical and Surgical Treatment


Attention: There is an updated edition available for this report.

Despite troublesome safety problems with past entrants into this market, the veritable epidemic of overweight and obesity continues to make this sector an extremely attractive target for pharmaceutical developers. This new title provides a considered view of the market for medical interventions in the battle against obesity, including U.S. and worldwide market size and growth forecasts, competitive market share and extensive pharmaceutical pipeline information.

The report discusses both prescription and OTC drug markets and surgical interventions. Market size and growth rates are provided through 2010 for:

  • Prescription Appetite Suppressants
  • Prescription Lipase Inhibitors
  • OTC Appetite Suppressants
  • OTC Fat Substitutes
  • Surgical Intervetion (dollar- and procedure volumes)

Complete epidemilogical data, detailed descriptions of over 50 compounds in development for this sector, and profiles of 14 top suppliers are provided as well.


  • Executive Summary
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table Market Summary: The World Market for Obesity Treatments 2000-2010
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
      • Table Revenues and Segments of Participation by Leading Market Participants (Prescription and OTC Markets) 2005
  • Introduction
    • OVERVIEW OF OBESITY AND WEIGHT MANAGEMENT
      • Definition of Overweight and Obesity
        • Table Body Mass Index (BMI) Chart
      • Homeostatic Mechanisms Controlling Energy Balance
      • Regulation of Energy Expenditure and Food Intake
      • Pathophysiology of Obesity
      • Causes of Overweight and Obesity
        • Table Causes of Overweight and Obesity
      • Health Risks
      • Economic Consequences
    • DEMOGRAPHICS
      • Table Percent Distributions of BMI Among Persons Age 18 and Over by Weight Characteristic (Underweight, Healthy Weight, Overweight, Obese) and Selected Demographic Characteristics (Age Group, Sex) 2003
    • OBESITY MANAGEMENT
  • Issues and Trends
    • OVER-THE COUNTER XENICAL
    • CORTISOL AND OBESITY
    • WEIGHT AND HEIGHT TRENDS
    • EDUCATIONAL EFFORTS OF PHYSICAL ACTIVITY
      • Sedentary Behavior in Overweight and Obese Persons
      • Role of Physical Activity in Body Weight Regulation
      • Educating Patients About the Benefits of Activity
    • FAT GENE MAPPING TOOL
    • LASER MELTS FAT
    • CILIARY NEUROTROPHIC FACTOR UPDATE
    • DRINKING AND OBESITY
    • EXERCISE GENE
    • TRENDS IN CHILDHOOD OBESITY
      • Table Prevalence of Obesity in Children and Adolescents 1976-2004
    • EFFECT OF MODERNIZATION ON OBESITY
      • Table Impact of Modernization on Obesity
    • INSURANCE COVERAGE ISSUES
      • Medicare
      • Medicaid
        • Table Medicaid Insurance Coverage by State (Xenical, Meridia, Phentermine) and Prior Authorization Requirments
      • Medicare Coverage of Bariatric Surgery
    • SELECTED WEIGHT LOSS PROGRAMS
      • Table Popular Weight Loss Programs
  • Prescription Pharmaceutical Market
    • DESCRIPTION OF PRODUCTS
      • Appetite Suppressants
        • Table Prescription Appetite Suppressant Medications
      • Lipase Inhibitors
    • MARKET SIZE AND GROWTH
      • World Market
        • Table The World Market for Prescription Anti-obesity and Weight Loss Drugs by Type (Appetite Suppressants, Lipase Inhibitors) 2000-2010
      • World Market and U.S. Market Analysis
        • Table The Market for Prescription Anti-Obesity and Weight Loss Drugs (U.S. vs World Revenues) 2000-2010
    • COMPETITIVE ANALYSIS
      • Table The World Market for Prescription Anti-obesity and Weight Loss Drugs, Revenues and Market Share by Supplier 2005
  • Over-the-Counter Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Appetite Suppressants
      • Fat Substitutes
      • Others
    • MARKET SIZE AND GROWTH
      • World Market
        • Table The World Market for Over-the-Counter Anti-obesity and Weight Loss Drugs by Type (Appetite Suppressants, Fat Substitutes) 2000-2010
      • World Market and U.S. Market Analysis
        • Table The Market for Over-the-Counter Anti-Obesity and Weight Loss Drugs (U.S. vs World Revenues) 2000-2010
    • COMPETITIVE ANALYSIS
  • Surgical Interventions
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
    • MARKET SIZE AND GROWTH
      • World Market
        • Table The World Market for Obesity Surgical Interventions 2000-2010
      • World Market and U.S. Market Analysis
        • Table The Market for Obesity Surgical Interventions (U.S. vs World Revenues) 2000-2010
    • PROCEDURE VOLUMES
      • Table Number of Bariatric Procedures 2000-2005
  • Pharmaceutical Research and Development
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • 5HT2-C Agonists
      • 5HT-6 Antagonists (BVT.5182)
      • Adiponectin (ACRP30 [Famoxin])
      • Amylin Analogs (Symlin [AC137])
      • Angiogenesis Inhibitors (TNP-470)
      • B-3AR Agonists
      • Botanical P57
      • Calpain-3
      • Cannabinoid-1 Receptor antagonists
      • CCK-A Agonists
      • Cholesterol Metabolites (MSI-1436)
      • Cholesterol Transport Inhibitors (FM-VP4)
      • Ciliary Neurotrophic Factor (CNTF) (Axokine)
      • Extendin-4 (AC3174)
      • Fatty Acid Synthase Inhibitor (C75)
      • Fibroblast Growth Factor-1 Inhibitor
      • FIT Gene and Ion Channel (CSX121, CSX 102 and CXS-829)
      • Ghrelin Antagonist
      • Histamine-3 Antagonists
      • Human Growth Hormone Fragments (AOD 9604)
      • Leptin Agonists (CBT 1452)
      • Lipase Inhibitors
      • Melanin Concentrating Hormone-1 Receptor Antagonists
      • Melanocortin-4 Receptor Agonists
      • Microsomal Triglyceride Transfer Protein (MTP) Inhibitor (SLx4090)
      • Neuropeptide y2 Receptor Antagonist
      • Neuropeptide Y Agonist (TM30338 and TM30339)
      • Neuropeptide Y5 Receptor Antagonist (S-2367)
      • Nicotine Receptor Ligand (TC-2216/TC-2286)
      • Obestatin
      • Oleoyl-estrone
      • Oleoylethanolamide
      • Osmotin
      • Oxyntomodulin
      • Peroxisome Proliferator Activated Receptor (GW501516)
      • Peroxisome Proliferator Activated Receptor-Pan Agonist (DRL 11605)
      • Gut Hormone Peptide (PYY)
      • Retinoid X Receptor: Peroxisome Proliferator Activated Receptor Agonists (LG100268)
      • RIP140 Inhibitor
      • Selective Androgen Receptor Modulator (SARM) (Ostarine)
      • Stearoyl-COA Desaturase-1
      • Thyroid Hormone-B Receptor Agonist (KB-2115)
      • Vaccines (CYT009)
      • Others
        • Table Anti-Obesity Pharmaceuticals in Research and Development
  • World Market Summary
    • OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table The World Market for Obesity Treatments Revenues by Segment 2000-2010
    • COMPETITOR ANALYSIS
      • Table Revenues and Segments of Participation by Leading Market Participants (Prescription and OTC Markets) 2005
  • Corporate Profiles
    • ABBOTT LABORATORIES
    • ALIZYME
    • ARENA PHARMACEUTICALS
    • CHEMGENEX PHARMACEUTICALS
    • GLAXOSMITHKLINE PLC
    • LIGAND PHARMACEUTICALS,INC
    • MANHATTAN PHARMACEUTICALS,INC
    • MERCK &COMPANY,INC.
    • METABOLIC PHARMACEUTICALS LIMITED
    • NOVARTIS
    • PROCTOR &GAMBLE
    • REGENERON PHARMACEUTICALS INC
    • ROCHE GROUP
    • SANOFI-AVENTIS
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report